Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025BloodOpen Access

Molecular gene panel analysis in aplastic anaemia: Diagnostic utility and clinical implications

View Full Paper
Ask AI
Bookmark
Share

Authors

FVFrancesco VersinoSGShreyans GandhiJMJianne Miran

Discussion

Loading...

Member takes

Overview

Analysis reveals 10% of aplastic anaemia cases with pathogenic mutations, suggesting clonal haematopoiesis plays a role in diagnosis.

Key Points

  • Pathogenic variants found in 10% of aplastic anaemia patients, indicating the disease's complex nature.
  • Major findings include DNMT3A and RUNX1 mutations linked to clonal haematopoiesis in aplastic anaemia cases.
  • Analysis utilized a molecular gene panel in patients diagnosed with aplastic anaemia and related conditions.
  • The presence of mutations implies a need for enhanced diagnostic methods and ongoing clinical monitoring.

Cite This Study

Versino et al. (2025) studied this question.

synapsesocial.com/papers/69362f364fa91c937236d33chttps://doi.org/10.1182/blood-2025-1711
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clonal architecture and dynamics of somatic evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria2025 · 1 citations
  2. 2Invariant patterns of global mutational signatures allow new fundamental insights in etiopathogenesis of bone marrow failure including aplastic anemia and myelodysplasia2025
  3. 3Next generation sequencing profiling of pediatric Acute Myeloid Leukemia reveals distinct genetic landscapes across cytogenetic subgroups2025
  4. 4MDS without clonal marker: When depth outperforms breadth2025
  5. 5Integrative clinical and molecular analysis of outcome in elderly African ancestry Acute Myeloid Leukemia2025